MARKET

MDXG

MDXG

Mimedx Group Inc
NASDAQ
9.44
-0.02
-0.21%
After Hours: 9.44 0 0.00% 17:31 12/12 EST
OPEN
9.39
PREV CLOSE
9.46
HIGH
9.46
LOW
9.21
VOLUME
515.86K
TURNOVER
--
52 WEEK HIGH
10.14
52 WEEK LOW
5.47
MARKET CAP
1.39B
P/E (TTM)
20.52
1D
5D
1M
3M
1Y
5Y
1D
Craig-Hallum Sticks to Their Buy Rating for MiMedx Group (MDXG)
TipRanks · 3d ago
Weekly Report: what happened at MDXG last week (1202-1206)?
Weekly Report · 4d ago
Weekly Report: what happened at MDXG last week (1125-1129)?
Weekly Report · 12/02 09:53
Northland Securities Sticks to Its Buy Rating for MiMedx Group (MDXG)
TipRanks · 11/27 14:25
Poseida Therapeutics, Inc. (PSTX) Hit a 52 Week High, Can the Run Continue?
NASDAQ · 11/27 14:15
Weekly Report: what happened at MDXG last week (1118-1122)?
Weekly Report · 11/25 09:50
How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12%
NASDAQ · 11/20 14:55
Weekly Report: what happened at MDXG last week (1111-1115)?
Weekly Report · 11/18 09:49
More
About MDXG
MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.

Webull offers MiMedx Group Inc stock information, including NASDAQ: MDXG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDXG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDXG stock methods without spending real money on the virtual paper trading platform.